Skip to main content
. 2018 Jul 2;19(7):1937. doi: 10.3390/ijms19071937

Table 1.

Viability of pancreatic cancer cells (MIA PaCa-2, BxPC-3, CFPAC-1 and ASPC-1) and non-tumorigenic pancreas cells (HPDE) when treated with 0–300 µM of oleuropein, hydroxytyrosol or tyrosol. Values represent concentration required to achieve a 50% reduction in viability (IC50).

Cell Line Oleuropein (µM) Hydroxytyrosol (µM) Tyrosol (µM) Gemcitabine (nM)
MIA PaCa-2 150.1 75.1 >300 31.02
BxPC-3 >300 >300 >300 3.6
CFPAC-1 >300 >300 >300 2.6
ASPC-1 >300 >300 >300 12
HPDE >300 65.5 >300 0.04